A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients
NCT02497417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1021
Last updated 2017-08-23
Summary
The ARIES C. difficile Assay is a real-time PCR based qualitative in vitro diagnostic test for the direct detection of C. difficile nucleic acid in stool specimens.
Conditions
- Gastroenteritis
- Infectious Colitis
Sponsors & Collaborators
-
Luminex Corporation
lead INDUSTRY
Principal Investigators
-
Ronald Dunn · Luminex Corporation
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- United States
Study Locations
More Related Trials
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
NCT02148601 ·Status: COMPLETED ·Phase: PHASE2
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED
-
C Difficile Near-patient Diagnostics
NCT03857464 ·Status: COMPLETED ·Phase: NA
-
Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.
NCT04910815 ·Status: RECRUITING ·Phase: NA
-
Early FMT for C.Difficile
NCT02465463 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
NCT06071312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Microbiome Determinants of Neurological and Gastrointestinal Symptoms of Autism Spectrum Disorder (ASD)
NCT05465148 ·Status: WITHDRAWN
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
Freeze-dried, Capsulized FMT for RCDI
NCT02399618 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase I Trial of a Single Dose of CRS3123
NCT01551004 ·Status: COMPLETED ·Phase: PHASE1
-
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
NCT03005379 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
NCT02951702 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
NCT02117570 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age
NCT03579459 ·Status: COMPLETED ·Phase: PHASE3
-
Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
NCT05873231 ·Status: RECRUITING
-
C.Difficile Observational Study
NCT06277999 ·Status: COMPLETED
-
Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years
NCT01706367 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplantation (FMT) for Clostridium Difficile
NCT03712722 ·Status: UNKNOWN
-
FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
NCT02254811 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers
NCT00214461 ·Status: COMPLETED ·Phase: PHASE1